Dr Savage is the Research Director of the Biomedical Manufacturing Platform at CSIRO and he will apply cutting edge proteomics methodologies to characterise the structure, function, post-translational modifications and molecular interactions of therapeutic peptides, proteins and protein complexes and will focus on the development of novel, engineered therapeutic proteins, especially antibodies, for the treatment of a variety of diseases and the use of different platform technologies for scale- up production. They will also focus on the application of novel conjugation/ligation technologies for the synthesis of bespoke “designer” proteins with novel functional activities.